9-130681605-TCGCCGCCGCCGCCGCCGCCGCCGC-TCGCCGCCGCCGC
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP3BP6_Very_StrongBS1
The NM_021619.3(PRDM12):c.1065_1076delCGCCGCCGCCGC(p.Ala356_Ala359del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000466 in 954,886 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00066 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00043 ( 0 hom. )
Consequence
PRDM12
NM_021619.3 disruptive_inframe_deletion
NM_021619.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.33
Genes affected
PRDM12 (HGNC:13997): (PR/SET domain 12) This gene encodes a transcriptional regulator of sensory neuronal specification that plays a critical role in pain perception. The encoded protein contains an N-terminal PRDI-BF1 and RIZ homology (PR) domain, a SET domain, and three C-terminal C2H2 zinc finger DNA-binding domains. Naturally occurring mutations in this gene are associated with congenital insensitivity to pain (CIP), and hereditary sensory and autonomic neuropathies (HSAN's) affecting peripheral sensory and autonomic neurons. Deregulation of this gene is associated with solid cancers and hematological malignancies including chronic myeloid leukaemia. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP3
Nonframeshift variant in repetitive region in NM_021619.3
BP6
Variant 9-130681605-TCGCCGCCGCCGC-T is Benign according to our data. Variant chr9-130681605-TCGCCGCCGCCGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 542462.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000433 (352/812972) while in subpopulation MID AF= 0.00187 (3/1600). AF 95% confidence interval is 0.00057. There are 0 homozygotes in gnomad4_exome. There are 160 alleles in male gnomad4_exome subpopulation. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDM12 | NM_021619.3 | c.1065_1076delCGCCGCCGCCGC | p.Ala356_Ala359del | disruptive_inframe_deletion | 5/5 | ENST00000253008.3 | NP_067632.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDM12 | ENST00000253008.3 | c.1065_1076delCGCCGCCGCCGC | p.Ala356_Ala359del | disruptive_inframe_deletion | 5/5 | 1 | NM_021619.3 | ENSP00000253008.2 | ||
PRDM12 | ENST00000676323.1 | c.906+159_906+170delCGCCGCCGCCGC | intron_variant | ENSP00000502471.1 |
Frequencies
GnomAD3 genomes AF: 0.000656 AC: 93AN: 141874Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
93
AN:
141874
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000433 AC: 352AN: 812972Hom.: 0 AF XY: 0.000424 AC XY: 160AN XY: 377090
GnomAD4 exome
AF:
AC:
352
AN:
812972
Hom.:
AF XY:
AC XY:
160
AN XY:
377090
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000655 AC: 93AN: 141914Hom.: 0 Cov.: 0 AF XY: 0.000655 AC XY: 45AN XY: 68752
GnomAD4 genome
AF:
AC:
93
AN:
141914
Hom.:
Cov.:
0
AF XY:
AC XY:
45
AN XY:
68752
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Congenital insensitivity to pain-hypohidrosis syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at